Literature DB >> 32265559

Second RNAi drug approved.

.   

Abstract

Year:  2020        PMID： 32265559     DOI： 10.1038/s41587-020-0494-3

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  12 in total

Review 1.  The Effect of miRNA Gene Regulation on HIV Disease.

Authors:  Romona Chinniah; Theolan Adimulam; Louansha Nandlal; Thilona Arumugam; Veron Ramsuran
Journal:  Front Genet       Date:  2022-05-04       Impact factor: 4.772

2.  Disulfide Bridging Strategies in Viral and Nonviral Platforms for Nucleic Acid Delivery.

Authors:  Kingshuk Dutta; Ritam Das; Jewel Medeiros; S Thayumanavan
Journal:  Biochemistry       Date:  2021-01-11       Impact factor: 3.162

Review 3.  The growth of siRNA-based therapeutics: Updated clinical studies.

Authors:  M May Zhang; Raman Bahal; Theodore P Rasmussen; José E Manautou; Xiao-Bo Zhong
Journal:  Biochem Pharmacol       Date:  2021-01-26       Impact factor: 6.100

Review 4.  Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma.

Authors:  Mariam Mroweh; Thomas Decaens; Patrice N Marche; Zuzana Macek Jilkova; Flora Clément
Journal:  Int J Mol Sci       Date:  2020-07-24       Impact factor: 5.923

Review 5.  Recent Advances in the Development of Exogenous dsRNA for the Induction of RNA Interference in Cancer Therapy.

Authors:  Tatiana S Golubeva; Viktoria A Cherenko; Konstantin E Orishchenko
Journal:  Molecules       Date:  2021-01-29       Impact factor: 4.411

Review 6.  The Limitless Future of RNA Therapeutics.

Authors:  Tulsi Ram Damase; Roman Sukhovershin; Christian Boada; Francesca Taraballi; Roderic I Pettigrew; John P Cooke
Journal:  Front Bioeng Biotechnol       Date:  2021-03-18

7.  DOCK2 regulates antifungal immunity by regulating RAC GTPase activity.

Authors:  Xiaojian Ma; Xi Tan; Bingbing Yu; Wanwei Sun; Heping Wang; Huijun Hu; Yanyun Du; Ruirui He; Ru Gao; Qianwen Peng; Zhihui Cui; Ting Pan; Xiong Feng; Junhan Wang; Chengqi Xu; Bin Zhu; Wei Liu; Chenhui Wang
Journal:  Cell Mol Immunol       Date:  2022-01-25       Impact factor: 22.096

8.  An RNA Interference/Adeno-Associated Virus Vector-Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus.

Authors:  Viet Loan Dao Thi; Dirk Grimm; Cindy Zhang; Andrew Freistaedter; Carolin Schmelas; Manuel Gunkel
Journal:  Hepatol Commun       Date:  2021-10-31

9.  Ligand conjugate SAR and enhanced delivery in NHP.

Authors:  Richard James Holland; Kieu Lam; Xin Ye; Alan D Martin; Mark C Wood; Lorne Palmer; David Fraser; Kevin McClintock; Sara Majeski; Agnes Jarosz; Amy C H Lee; Emily P Thi; Adam Judge; James Heyes
Journal:  Mol Ther       Date:  2021-06-04       Impact factor: 12.910

10.  Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases.

Authors:  Flora Clément; Adrien Nougarède; Stéphanie Combe; Frédérique Kermarrec; Arindam K Dey; Patricia Obeid; Arnaud Millet; Fabrice P Navarro; Patrice N Marche; Eric Sulpice; Xavier Gidrol
Journal:  J Crohns Colitis       Date:  2022-02-23       Impact factor: 9.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.